442-N RNA primed SMAR-TTM cells against multiple driver mutations, all HLA’s, designed for first line therapy

• Walter Barry,
• Farzonai Muzaffar,
• Sriram Srivatsa,
• Ground Entrance,
• Ryan Campbell,
• Abenezer Abera,
• Alfred E Slanetz

Affiliations

Walter Barry

1Geneius Biotechnology, Inc., Natick, MA, USA

Farzonai Muzaffar

1Geneius Biotechnology, Inc., Natick, MA, USA

Sriram Srivatsa

1Geneius Biotechnology, Inc., Natick, MA, USA

Ground Entrance

1Geneius Biotechnology, Inc., Natick, MA, USA

Ryan Campbell

1Geneius Biotechnology, Inc., Natick, MA, USA

Abenezer Abera

1Geneius Biotechnology, Inc., Natick, MA, USA

Alfred E Slanetz

2Geneius Biotechnology, Cohasset, MA, USA